Long-Term Assets: The sum of all assets classified as non-current.
Faeth Therapeutics, Inc. (FTH) had Long-Term Assets of $0.65M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-16.01M |
|
-- |
|
-- |
|
$18.39M |
|
$-18.39M |
|
$2.38M |
|
$-16.01M |
|
$-16.01M |
|
$-16.01M |
|
$-16.01M |
|
$-16.01M |
|
$-16.01M |
|
$-18.39M |
|
$-18.36M |
|
5.64M |
|
5.64M |
|
$-2.84 |
|
$-2.84 |
|
| Balance Sheet Financials | |
$188.66M |
|
$0.04M |
|
|
Long-Term Assets |
$0.65M |
$189.31M |
|
$9.58M |
|
-- |
|
$6.77M |
|
$16.35M |
|
$172.96M |
|
$172.96M |
|
$172.96M |
|
25.83M |
|
| Cash Flow Statement Financials | |
$-26.41M |
|
$-139.50M |
|
$184.14M |
|
$8.67M |
|
$26.90M |
|
$18.23M |
|
$17.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.69 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.25% |
|
-9.25% |
|
-8.46% |
|
-9.25% |
|
$6.70 |
|
$-4.68 |
|
$-4.68 |
|